We are live on ! Find out more
CBST

CUBIST PHARMACEUTICALS INC
CBST

Delisted

CBST was delisted on the 21st of January, 2015.

Back to rankings

270 hedge funds and large institutions have $5.5B invested in CUBIST PHARMACEUTICALS INC in 2014 Q2 according to their latest regulatory filings, with 35 funds opening new positions, 109 increasing their positions, 86 reducing their positions, and 41 closing their positions.

New
Increased
Maintained
Reduced
Closed

27% more repeat investments, than reductions

Existing positions increased: 109 | Existing positions reduced: 86

0% more funds holding in top 10

Funds holding in top 10: 8 → 8 (0)

2% less funds holding

Funds holding: 276 → 270 (-6)

15% less first-time investments, than exits

New positions opened: 35 | Existing positions closed: 41

29% less capital invested

Capital invested by funds: $7.7B → $5.5B (-$2.21B)

96% less call options, than puts

Call options by funds: $16.1M | Put options by funds: $446M

Holders
270
Holders Change
-6
Holders Change %
-2.17%
% of All Funds
7.76%
Holding in Top 10
8
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.23%
New
35
Increased
109
Reduced
86
Closed
41
Calls
$16.1M
Puts
$446M
Net Calls
-$430M
Net Calls Change
-$419M

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$46.5M
2
PI
Putnam Investments
Massachusetts
+$42.3M
3
Bank of New York Mellon
Bank of New York Mellon
New York
+$41.7M
4
Westfield Capital Management
Westfield Capital Management
Massachusetts
+$36.5M
5
HM
HealthCor Management
New York
+$34M

Top Sellers

Rank Fund Capital Flow
1
BNP Paribas Financial Markets
BNP Paribas Financial Markets
France
-$576M
2
MC
Maverick Capital
Texas
-$127M
3
EAM
Eagle Asset Management
Florida
-$38.5M
4
Federated Hermes
Federated Hermes
Pennsylvania
-$29.5M
5
CAM
Cormorant Asset Management
Massachusetts
-$21.9M
Name Holding Trade Value Shares
Change 		Change in
Stake
UOC
126
UBS O'Connor
Illinois
$2.96M +$2.88M +42,400 New
WMSA
127
Weiss Multi-Strategy Advisers
New York
$2.86M -$10.2K -150 -0.4%
CGI
128
CI Global Investments
California
$2.79M +$2.72M +40,000 New
RSCM
129
Rock Springs Capital Management
Maryland
$2.72M +$612K +9,000 +30%
MSA
130
Mason Street Advisors
Wisconsin
$2.61M +$5.99K +88 +0.2%
GF
131
Gabelli Funds
New York
$2.58M +$2.52M +37,000 New
Marshall Wace
132
Marshall Wace
United Kingdom
$2.56M +$2.5M +36,696 New
Fisher Asset Management
133
Fisher Asset Management
Washington
$2.54M +$2.48M +36,450 New
SOMRS
134
State of Michigan Retirement System
Michigan
$2.48M +$20.4K +300 +0.9%
SCM
135
Stevens Capital Management
Pennsylvania
$2.48M +$2.41M +35,455 New
3NC
136
300 North Capital
California
$2.43M +$113K +1,657 +5%
Two Sigma Advisers
137
Two Sigma Advisers
New York
$2.43M +$1.98M +29,100 +515%
STC
138
SEI Trust Company
Pennsylvania
$2.36M -$55K -808 -2%
ARTA
139
A.R.T. Advisors
New York
$2.34M +$2.28M +33,497 New
PP
140
PDT Partners
New York
$2.29M +$1.78M +26,109 +387%
WB
141
WesBanco Bank
West Virginia
$2.29M -$1.7K -25 -0.1%
RFC
142
Russell Frank Company
Washington
$2.27M -$84.5K -1,243 -3%
PPA
143
Parametric Portfolio Associates
Washington
$2.26M +$183K +2,688 +9%
Macquarie Group
144
Macquarie Group
Australia
$2.09M +$55.9K +822 +3%
EAM
145
Eventide Asset Management
Massachusetts
$2.02M +$109K +1,600 +6%
Bank of Nova Scotia
146
Bank of Nova Scotia
Ontario, Canada
$2.02M +$136K +2,000 +7%
NCCM
147
Nine Chapters Capital Management
New Jersey
$2M +$1.95M +28,700 New
TD Asset Management
148
TD Asset Management
Ontario, Canada
$1.99M -$47.6K -700 -2%
OA
149
Oxbow Advisors
Texas
$1.89M – – –
CCMH
150
Cornerstone Capital Management Holdings
New York
$1.88M -$3.47M -50,998 -65%
4 5
6
7 8

CBST Hedge Fund Activity: Q2 2014 in Review

270 of the 3,480 institutional investors tracked by Wall St. Rank reported a position in CUBIST PHARMACEUTICALS INC (CBST) for Q2 2014, worth a combined $5.5B — down 29% from $7.7B a quarter earlier.

Sellers outnumbered buyers: 41 funds closed out of CBST and 35 opened new positions — a net loss of 6 holders — while 86 trimmed existing stakes and 109 added.

The largest buyer was Fidelity Investments, adding an estimated $46.5M. The largest seller was BNP Paribas Financial Markets, cutting an estimated $576M.

  • 270 institutional investors held CUBIST PHARMACEUTICALS INC (CBST) as of Q2 2014, down from 276 in Q1 2014.
  • Funds reported $5.5B of CUBIST PHARMACEUTICALS INC stock for Q2 2014, down 29% quarter-over-quarter.
  • 35 funds opened new CUBIST PHARMACEUTICALS INC positions in Q2 2014 and 41 closed out, a net change of -6 holders.
  • The largest CUBIST PHARMACEUTICALS INC buyer in Q2 2014 was Fidelity Investments, an estimated $46.5M added.
  • The largest CUBIST PHARMACEUTICALS INC seller in Q2 2014 was BNP Paribas Financial Markets, an estimated $576M sold.

Based on aggregated 13F filings for Q2 2014.